Nova Patents
ES2961925T3

Biomarkers for irritable bowel syndrome

Abstract

The present invention relates to a method for determining the likelihood that an individual has irritable bowel syndrome and whether the individual will respond to a dietary intervention. The present invention also provides a method for determining the likelihood that an individual with irritable bowel syndrome will respond to a dietary intervention. Also provided is the use of a compound as defined herein as a biomarker. (Automatic translation with Google Translate, without legal value)

ES2961925T3, drawing sheet 1
Sheet 1 of 4

Term

13.8 yearsto projected expiry

Projected expiry 3 July 2040, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

4 sheets

  1. Sheet 1
  2. Sheet 2
  3. Sheet 3
  4. Sheet 4